BioCentury
ARTICLE | Company News

AstraZeneca sales and marketing update

February 20, 2012 8:00 AM UTC

AstraZeneca launched a new service to deliver Arimidex anastrozole to breast cancer patients in the U.S. via Express Scripts Inc. (NASDAQ:ESRX, St. Louis, Mo.) for $40 per month, including shipping....